An Investigator Sponsored Phase I Trial of Selinexor Combined With Standard Capecitabine Based Chemoradiation as a Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Trial Profile

An Investigator Sponsored Phase I Trial of Selinexor Combined With Standard Capecitabine Based Chemoradiation as a Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Sep 2017

At a glance

  • Drugs Selinexor (Primary) ; Capecitabine
  • Indications Rectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 11 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top